Canada markets open in 4 hours 44 minutes

Orchard Therapeutics plc (ORTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.4100-0.0500 (-3.42%)
At close: 1:00PM EST
1.4600 +0.05 (+3.55%)
After hours: 03:45PM EST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
1,192
2,595
2,513
2,076
-
Cost of Revenue
225
857
805
422
-
Gross Profit
967
1,738
1,708
1,654
-
Operating Expenses
Research Development
86,279
93,730
117,363
205,319
32,527
Selling General and Administrative
57,579
64,986
57,218
31,366
5,985
Total Operating Expenses
143,858
158,716
174,581
236,685
38,512
Operating Income or Loss
-142,891
-156,978
-172,873
-235,031
-38,512
Interest Expense
2,389
2,328
1,538
-
-
Total Other Income/Expenses Net
3,585
3,411
7,211
5,506
-1,179
Income Before Tax
-141,067
-152,710
-165,662
-229,525
-39,691
Income Tax Expense
789
-731
-2,240
970
53
Income from Continuing Operations
-141,856
-151,979
-163,422
-230,495
-39,744
Net Income
-141,856
-151,979
-163,422
-230,495
-39,744
Net Income available to common shareholders
-141,856
-151,979
-163,422
-230,495
-39,744
Basic EPS
-
-1.53
-1.75
-10.22
-4.48
Diluted EPS
-
-1.53
-1.75
-10.22
-4.48
Basic Average Shares
-
99,446
93,240
22,559
8,873
Diluted Average Shares
-
99,446
93,240
22,559
8,873
EBITDA
-
-148,378
-171,198
-233,832
-38,210